Aisix wildfire modelling validated by Canada's 2025 fire season
Aisix's wildfire modelling was built from its BurnP3+ framework, which integrates machine learning, physics-based modelling, and climate projections to simulate wildfire behaviour
More than 20,000 square kilometers have burned across the country so far this year
Aisix stock (TSXV:AISX) opened at $0.05
As Canada grapples with one of its most destructive wildfire seasons in recent memory, Aisix Solutions (TSXV:AISX), a provider of wildfire data and analytics, has announced that its predictive wildfire modelling has been tragically validated by real-world events.
In early 2025, Aisix released two key reports: Top 10 Canadian small population centres at risk of wildfires and Top ten small Ontario municipalities at risk of wildfires . These reports identified several communities at heightened risk—some of which are now facing severe wildfire impacts. Among them are Fort Smith, Swan Hills, and Kenora, all currently experiencing devastating fires.
'The fires we are currently seeing in communities highlighted in Aisix's reports underscore the urgent need for proactive risk management and the value that wildfire intelligence can deliver to governments, industry, and communities alike,' Aisix Solutions' CEO, Mihalis Belantis said in a news release.
According to the Canadian Wildland Fire Information System, more than 20,000 square kilometers have burned across the country so far this year. The Associated Press reports that over 25,000 residents have been evacuated from Manitoba, Saskatchewan, and Alberta.
Aisix's wildfire modelling was built from its BurnP3+ framework, which integrates machine learning, physics-based modelling, and climate projections to simulate wildfire behaviour under both current and future climate conditions. This advanced approach has enabled the company to pinpoint high-risk areas with remarkable accuracy.
In February 2025, Aisix scored a contract with the Climate Risk division of a major S&P 500 company to provide wildfire modelling data, initially focusing on Alberta with plans to expand nationwide. The company's Wildfire 3.0 data is now being used by governments, insurers, infrastructure operators, and emergency response teams to better understand and respond to wildfire threats.
As wildfire seasons grow longer and more intense due to climate change, Aisix emphasizes that historical data alone is no longer sufficient. The company is inviting stakeholders to request a demo of Wildfire 3.0 to explore how its predictive modelling can support risk mitigation, emergency preparedness, and climate resilience strategies.
Aisix Solutions helps people, businesses and governments around the world analyze, manage and mitigate climate-related risks.
Aisix stock (TSXV:AISX) opened 30 per cent higher at $0.05.
Join the discussion: Find out what everybody's saying about this AI stock on the Aisix Solutions Inc. Bullboard and check out the rest of Stockhouse's stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
32 minutes ago
- Cision Canada
Air Canada and Air Canada Rouge Flights Suspended due to a Strike By CUPE Flight Attendants
Air Canada Jazz and PAL Airlines flights continue to operate as usual MONTRÉAL, Aug. 16, 2025 /CNW/ - Air Canada today said that it has suspended all operations of Air Canada and Air Canada Rouge due to a strike by its 10,000 flight attendants represented by the Canadian Union of Public Employees (CUPE). The strike took effect at 12:58 am Eastern Time on August 16, 2025. Flights by Air Canada Express, which are operated by third-party airlines, are not affected. CUPE served Air Canada the statutory 72-hour strike notice on August 13, 2025. The airline has since been gradually reducing its schedule of approximately 700 daily flights to manage the labour disruption created by CUPE's strike notice, while working diligently to reach a new, negotiated collective agreement and avoid further labour disruption. Approximately 130,000 customers will be impacted each day that the strike continues. Air Canada is strongly advising affected customers not to go to the airport unless they have a confirmed ticket on an airline other than Air Canada or Air Canada Rouge. Air Canada will notify customers with imminent travel of additional cancelled flights and their options. For those customers due to travel soon whose flights are not yet cancelled, Air Canada has put in place a goodwill policy to allow them to rebook their travel or obtain a credit for future travel. For more information customers should visit Air Canada deeply regrets the effect the strike is having on customers. About Air Canada Air Canada is Canada's largest airline, the country's flag carrier and a founding member of Star Alliance, the world's most comprehensive air transportation network. Air Canada provides scheduled service directly to more than 180 airports in Canada, the United States and Internationally on six continents. It holds a Four-Star ranking from Skytrax. Air Canada's Aeroplan program is Canada's premier travel loyalty program, where members can earn or redeem points on the world's largest airline partner network of 45 airlines, plus through an extensive range of merchandise, hotel and car rental partners. Through Air Canada Vacations, it offers more travel choices than any other Canadian tour operator to hundreds of destinations worldwide, with a wide selection of hotels, flights, cruises, day tours, and car rentals. Its freight division, Air Canada Cargo, provides air freight lift and connectivity to hundreds of destinations across six continents using Air Canada's passenger and freighter aircraft. Air Canada's climate-related ambition includes a long-term aspirational goal of net-zero greenhouse gas emissions by 2050. For additional information, please see Air Canada's TCFD disclosure. Air Canada shares are publicly traded on the TSX in Canada and the OTCQX in the US. Sign up for Air Canada news: Media Resources: Photos Videos B-Roll Articles SOURCE Air Canada
Globe and Mail
5 hours ago
- Globe and Mail
How major US stock indexes fared Wednesday, 8/13/2025
U.S. stocks notched some more records as a rally spurred by hopes for lower U.S. interest rates wrapped around the world. The S&P 500 rose 0.3% Wednesday. The Dow Jones Industrial Average climbed 1%, while the Nasdaq added 0.1% to its record set the day before. Treasury yields eased, as expectations reached a virtual consensus that the Federal Reserve will cut its main interest rate for the first time this year at its next meeting in September. On Wednesday: The S&P 500 rose 20.82 points, or 0.3%, to 6,466.58. The Dow Jones Industrial Average rose 463.66 points, or 1%, to 44,922.27. The Nasdaq composite rose 31.24 points, or 0.1%, to 21,713.14. The Russell 2000 index of smaller companies rose 45.28 points, or 2%, to 2,228.06. For the week: The S&P 500 is up 77.13 points, or 1.2%. The Dow is up 746.66 points, or 1.7%. The Nasdaq is up 263.12 points, or 1.2%. The Russell 2000 is up 109.64 points, or 4.9%. For the year: The S&P 500 is up 584.95 points, or 9.9%. The Dow is up 2,378.05 points, or 5.6%. The Nasdaq is up 2,402.35 points, or 12.4%. The Russell 2000 is up 97.90 points, or 4.4%.
Cision Canada
6 hours ago
- Cision Canada
ZYUS Life Sciences Announces Closing of Second Tranche of Unit Offering
SASKATOON, SK, Aug. 15, 2025 /CNW/ - ZYUS Life Sciences Corporation (the " Company") (TSXV: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that, further to its press release dated July 29, 2025, it has closed the second tranche (the " Second Tranche") of its non-brokered private placement (the " Offering") of units of the Company (each a " Unit") for up to CAD $1,000,000. Under the Second Tranche of the Offering, a further 140,845 Units were issued for aggregate gross proceeds of CAD $100,000. The aggregate gross proceeds raised in the Second Tranche and first tranche of the Offering (which closed on July 29, 2025) (the " First Tranche") is approximately $0.42 million. The Company has issued a total of 591,126 Units each priced at $0.71 per Unit in the First Tranche and the Second Tranche. Each Unit consists of one common share of the Company (a " Common Share") and one Common Share purchase warrant (each Common Share purchase warrant, a " Warrant"), whereby each Warrant entitles the holder to acquire one Common Share at a price of $0.95 for a period of twenty-four months from the date of issuance, unless the term of the Warrant is accelerated pursuant to its terms (the " Acceleration Provision"). In accordance with the Acceleration Provision, if the volume-weighted average trading price of the Common Shares is greater than $3.00 for a period of 5 consecutive trading days on the TSX Venture Exchange (the " TSXV"), the Company will have the right to accelerate the expiry date of the Warrants. Proceeds of the Offering will be used for general corporate and working capital purposes. No finder's fees were paid in connection with the Offering. The Units were offered by way of private placement pursuant to exemptions from prospectus requirements under applicable securities laws. All securities issued under the First Tranche are subject to a hold period expiring November 30, 2025, and all securities issued under the Second Tranche of the Offering are subject to a hold period expiring December 16, 2025, in accordance with applicable securities laws and the policies of the TSXV. The Offering has received conditional approval from the TSXV and remains subject to final acceptance of the TSXV. The securities described herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act"), or any state securities laws, and may not be offered or sold within the United States or to, or for account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act and applicable state securities laws or pursuant to available exemptions therefrom. This release does not constitute an offer to sell or a solicitation of an offer to buy of any securities in the United States. About ZYUS Life Sciences Corporation ZYUS (TSXV: ZYUS) is a life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management. Through rigorous scientific exploration and clinical research, ZYUS aims to secure intellectual property protection, safeguarding its innovative therapies and bolstering shareholder value. ZYUS' unwavering commitment extends to obtaining regulatory approval of non-opioid-based pharmaceutical solutions, in pursuit of transformational impact on patients' lives. For additional information, visit or follow us on X @ZYUSCorp. Cautionary Note Regarding Forward-Looking Statements This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, receipt of TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering. Any such forward-looking statements may be identified by words such as "expects", "anticipates", "intends", "contemplates", "believes", "projects", "plans", "will" and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. Statements about, among other things, the Company's business, the Company's ability to advance clinical research activities, obtain regulatory approval of cannabinoid-based pharmaceutical drug candidates and introduce products that act as alternatives to current pain management therapies such as opioids, obtain TSXV final acceptance, closing of any additional tranche of the Offering and use of proceeds from the Offering are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that the Company will be able to achieve these results. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release.
